Details for 2018801838

Up to date per 02.04.2026

Actions

Title / Product Name

VERFAHREN ZUR VERWENDUNG VON LÖSLICHEM CD24 FÜR NEUROPROTEKTION UND REMYELINISIERUNG

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2018801838

EP Publication Number

3624838

E-Number

1545501

Language

PCT Number

US18032699

Publication Date

25.03.2020 A

25.01.2023 B1

Registration Date

25.01.2023

AT Publication Date

15.02.2023

Application Date

15.05.2018

Registration Number

Priorities

15.05.2017

201762506135 P

IPC

A61K 38/17 20060101AFI20210119BHEP

Maximum Duration of Protection

15.05.2038

Owner

Oncoimmune, Inc.9430 Key West Avenue Suite 113 Rockville, Maryland 20850US

Children's National Medical Center111 Michigan Avenue N.W. Washington, DC 20010US

Representative

No representatives present

Inventor

LIU, Yang502 E Street NE Washington District of Columbia 20002US

ZHENG, Pan502 E Street NE Washington District of Columbia 20002US

LI, Ning3127 Burris Rd. Apt. 17 Vestal New York 13850-2873US

DEVENPORT, Martin614 Still Creek Lane Gaithersburg Maryland 20878US